Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. - Wikidata - wikimedia - TriplyDB

Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.

Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.

http://www.wikidata.org/entity/Q39346165

about

Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease.Combined Dual Channel Impedance/pH-metry in Patients With Suspected Laryngopharyngeal Reflux Management of laryngopharyngeal reflux with proton pump inhibitors.Clinical manifestations and role of proton pump inhibitors in the management of laryngopharyngeal reflux.Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux.Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux.How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?Surgical Treatment of Extraesophageal Manifestations of Gastroesophageal Reflux Disease.Optimal treatment of laryngopharyngeal reflux disease.Effect of different pH criteria on dual-sensor pH monitoring in the evaluation of supraesophageal gastric reflux in children Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus.Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report.Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis.Reflux and Voice Disorders: Have We Established Causality?Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease.Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux.Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study.Analyzing the Area Under the Curve of Pharyngeal pH Probes in the Diagnosis of Reflux Disease

P2860

Q24243768-FA29D038-DDFE-4F74-9E92-3B489A1F10B2 Q30442218-571F2795-CA04-4FF8-9345-1D73C9880CDC Q33890515-8A3ADD94-D99A-4179-B847-0C2BF5CC182E Q34814157-6104B39F-E0CE-48C6-A639-7AFC80B37AC3 Q35007613-F6CA010F-50C7-4027-ABCC-17C4D86A8853 Q35268223-C4AC50DF-8F46-4281-8811-16B08352A1B3 Q36055038-D4321707-FBE7-480D-85A8-427AD1C45D3E Q36068820-3A32E5B9-3BEF-4B5A-9E8C-6EA3018E8F37 Q36215530-5906CAEE-35F8-4D59-9F79-5CF65DF7BF0C Q36372774-B4541DAF-FDDB-4459-AEFA-EF87D9A356DF Q37253915-7A9B0023-29C4-4ECE-82C0-D03A11016338 Q37424250-3661020F-0BBC-4DDC-A90F-57852B8177B1 Q37762466-3000A4C1-1C34-4196-B591-DBAA335D7CCD Q38950836-3C8BC90F-529F-4E6B-960E-3F2C0CD3BFD4 Q38982820-5CBB79FD-6B30-4361-96BB-3437288FA514 Q39121249-09D39FFE-5D9F-4FD0-AD2F-ACABEEE272E9 Q41877674-D4949C1A-5FF3-4BB8-AC87-8E898DA96699 Q46414941-D122B879-5C73-42F0-8DA4-40400F6EEE73 Q48640572-0CE80676-9A4D-41B8-ABB8-B98DDF657ACE Q58889864-3A24375A-989C-4D51-8F1C-B5733BF59704

P2860

Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.

http://www.wikidata.org/entity/Q39346165

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Double-blind, placebo-controll ...... for laryngopharyngeal reflux.

@en

Double-blind, placebo-controll ...... for laryngopharyngeal reflux.

@nl

type

label

Double-blind, placebo-controll ...... for laryngopharyngeal reflux.

@en

Double-blind, placebo-controll ...... for laryngopharyngeal reflux.

@nl

prefLabel

Double-blind, placebo-controll ...... for laryngopharyngeal reflux.

@en

Double-blind, placebo-controll ...... for laryngopharyngeal reflux.

@nl

P1433

Q39346165-217A9AD9-DECC-4EAC-A0C7-66BE2396C427

P1476

Q39346165-94514167-144D-4902-A270-047E6058B735

P2093

Q39346165-0473602B-9014-4E13-8FD3-152534B65D95

Q39346165-31A9D41D-A03A-4708-9C8C-B01042896EFE

Q39346165-49A9533B-C078-4EF6-94F1-346FFF015359

Q39346165-8DC78129-8F8D-44D5-BA2E-6B00E5FAA035

Q39346165-C8F2B36A-FC86-40B2-B1C2-957F64FE9B6C

Q39346165-DDE230E2-2F00-4191-A6A2-57509A990588

P2860

Q39346165-074C8243-E744-4D3E-9876-10F8E3F4AF70

Q39346165-1EA21709-CD86-4BE8-BF8B-A88B88BB62F3

Q39346165-297F25B4-16BB-4416-952D-1FD6897B57D8

Q39346165-488651DE-FE43-4AA3-81A6-9AE383F6B12D

Q39346165-5B9B4262-FD57-4CC1-9BCD-339C329C532A

Q39346165-5FEA1E7F-7447-413E-9E3D-BC75D9C70EDF

Q39346165-82054EB2-DF4A-435A-AC87-55A8FC9EF536

Q39346165-8BC2FC64-9DBB-4C8E-8226-5E749D93BEC4

Q39346165-C025C512-050F-4C96-8C82-21584324BB13

Q39346165-C65D9843-E3A4-4AFD-81E5-BDD5F28955CC

P304

Q39346165-7626B1E5-6631-4822-A1DD-44B5885FF290

P31

Q39346165-8CCDBA75-7ECC-4F6B-9D67-5AA1E2AB74C8

P356

Q39346165-4D7D95F4-D38A-4C68-B232-483970B91361

P407

Q39346165-20DE0563-4753-45A5-AA50-D7927B492BB8

P433

Q39346165-E0D6FE85-B1F7-4212-AB40-CEB31EE54A80

P478

Q39346165-72B91725-81E6-449C-AEEB-1FC25B666E0A

P577

Q39346165-A5260E4E-7853-4735-9FD4-9D1911AE77A5

P698

Q39346165-A0EDF36C-E101-4DA0-A67B-DDAB293CAB38

P921

Q39346165-D3F2D275-0ACF-43E6-B291-C83E033180A5

P356

J.1572-0241.2006.00693.X

P1433

The American Journal of Gastroenterology

P1476

Double-blind, placebo-controll ...... for laryngopharyngeal reflux.

@en

P2093

Eric Lentsch

http://www.w3.org/2001/XMLSchema#string

Jennifer Koopman

http://www.w3.org/2001/XMLSchema#string

John M Wo

http://www.w3.org/2001/XMLSchema#string

Ken Parker

http://www.w3.org/2001/XMLSchema#string

Steven P Harrell

http://www.w3.org/2001/XMLSchema#string

Welby Winstead

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.

Evaluation of professional singers.

Artefacts in 24-h pharyngeal and oesophageal pH monitoring: is simplification of pH data analysis feasible?

Reflex-mediated enhancement of airway protective mechanisms.

The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers.

Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study.

Treatment of chronic posterior laryngitis with esomeprazole.

Monitoring of laryngopharyngeal reflux: influence of meals and beverages.

Outcomes of antireflux therapy for the treatment of chronic laryngitis.

Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.

P304

1972-8; quiz 2169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2006.00693.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16968502

http://www.w3.org/2001/XMLSchema#string

P921